Møller S, Grunnet K, Hansen S, Schult H, Holmberg M, Sorensen M. A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy. AO [Internet]. 2012 Jul. 1 [cited 2026 May 18];51(6):797-804. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/31585